Ivermectin: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | == |
+ | ==Background== |
| + | ===Indications=== |
||
| ⚫ | |||
| + | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| + | |||
| + | ===Pharmacokinetics and Pharmacodynamics=== |
||
| + | |||
| + | *Does not cross blood-brain barrier |
||
| + | |||
| + | ==Dosing== |
||
| + | |||
| + | *Usual dose is 150-200 mcg/kg PO or SC once |
||
| + | |||
| + | ==Safety== |
||
| + | |||
| + | ===Adverse Effects=== |
||
| + | |||
| + | *Most common side effects are mild, including pruritus (25.3%), headache (13.9%), and dizziness (7.5%) |
||
| + | *Occasionally causes Mazzotti-type reaction in [[onchocerciasis]], characterized by fever, pruritus, tender lymphadenopathy, arthralgias and myalgias |
||
| + | *Rarely causes hypotension |
||
[[Category:Antihelminthics]] |
[[Category:Antihelminthics]] |
||
Latest revision as of 14:23, 11 April 2021
Background
Indications
Pharmacokinetics and Pharmacodynamics
- Does not cross blood-brain barrier
Dosing
- Usual dose is 150-200 mcg/kg PO or SC once
Safety
Adverse Effects
- Most common side effects are mild, including pruritus (25.3%), headache (13.9%), and dizziness (7.5%)
- Occasionally causes Mazzotti-type reaction in onchocerciasis, characterized by fever, pruritus, tender lymphadenopathy, arthralgias and myalgias
- Rarely causes hypotension
